Ivano Mezzaroma

6PUBLICATIONS
20CO-AUTHORS
Behavioural epidemiologyRegenerative medicine (incl. stem cells)Innate immunityRheumatology and arthritisFrench language
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 18, 2025
Efficacy, safety, and anti-inflammatory properties of the switch to a doravirine-based regimen among antiretroviral-experienced elderly people living with HIV-1: the DORAGE cohort.

Alessandro Lazzaro, Gregorio Egidio Recchia, Federica Alessi

|Jun 28, 2023
Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort.

Alessandro Lazzaro, Diana Bianchini, Elio Gentilini Cacciola

|Jan 21, 2023
The Many Faces of Immune Activation in HIV-1 Infection: A Multifactorial Interconnection.

Laura Mazzuti, Ombretta Turriziani, Ivano Mezzaroma

|Sep 23, 2022
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients.

Chiara Pellicano, Amalia Colalillo, Valerio Basile

|Mar 10, 2022
Long-Term Subjective and Objective Assessment of Smell and Taste in COVID-19.

Andrea Ciofalo, Carlo Cavaliere, Simonetta Masieri

|Jan 21, 2022
Switching to a Bictegravir Single Tablet Regimen in Elderly People Living with HIV-1: Data Analysis from the BICTEL Cohort.

Alessandro Lazzaro, Elio Gentilini Cacciola, Cristian Borrazzo

Pageof 1

Frequent Collaborators

3 joint publications

Claudio Maria Mastroianni

3 joint publications

Gabriella d'Ettorre

2 joint publications

Giancarlo Ceccarelli

2 joint publications

Letizia Santinelli